News DeskCairo, Egypt – International law firm Addleshaw Goddard has advised Alameda Healthcare, Egypt’s leading private healthcare group, on its $190 million minority investment agreement with London-based private equity firm Development Partners International (DPI) and its co-investors. The transaction, structured primarily as a capital increase, is expected to close in the third quarter of 2025, subject to customary regulatory approvals.
The deal marks the largest private equity investment of its kind in Egypt’s healthcare sector to date and represents a major milestone for both Alameda and DPI. It will enable Alameda to accelerate its strategic expansion across Egypt and into Gulf markets, further advancing its ambition to position Egypt as a regional hub for world-class healthcare.
The proceeds from the investment will be used to scale the Group’s hospital and outpatient network, invest in cutting-edge clinical technologies, and expand its Centres of Excellence in specialised medical fields such as cardiology, oncology, and liver disease. The funding will also support talent development initiatives aimed at retaining and upskilling Egyptian medical professionals and reversing brain drain from the sector.
Founded in 1999, Alameda operates two flagship hospital brands – As-Salam International and Dar Al Fouad – alongside seven polyclinics, a rehabilitation centre, home healthcare provider Tabibi 24/7, and a range of diagnostic, laboratory, and pharmacy services. It is the only private healthcare group in Egypt with full Joint Commission International (JCI) accreditation across all its hospitals, underscoring its commitment to quality and safety in patient care.
Philip Dowsett, Partner and Head of Investment Management and Funds at Addleshaw Goddard MENA, commented: “We are proud to have supported Alameda Healthcare on a transaction of such strategic significance. DPI’s investment reflects growing global confidence in Egypt’s healthcare infrastructure and Alameda’s leadership position within it. This deal also demonstrates our ability to advise on transformative cross-border investments that deliver regional impact.”
Addleshaw Goddard served as international legal counsel to Alameda Healthcare. The firm’s role included advising on transaction structuring, investor negotiations, and regulatory matters across multiple jurisdictions.
This transaction further reinforces Addleshaw Goddard’s strength in advising on complex, high-value investments in the healthcare, private equity, and emerging markets sectors throughout the Middle East and Africa.
